Skip to Main Content

Author Details

Cheryl H Arrowsmith
University of Toronto
1989
401
86
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36253570PBRM1, SETD2 and BAP1 - the trinity of 3p in clear cell renal cell carcinoma.Nat Rev Urol2023
37556795SETDB1 Triple Tudor Domain Ligand, (<i>R</i>,<i>R</i>)-59, Promotes Methylation of Akt1 in Cells.ACS Chem Biol2023
37549269SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.Proc Natl Acad Sci U S A2023
37600767The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population.Front Immunol2023
37390814Delineation of functional subdomains of Huntingtin protein and their interaction with HAP40.Structure2023
37350740Discovery of a Novel DCAF1 Ligand Using a Drug-Target Interaction Prediction Model: Generalizing Machine Learning to New Drug Targets.J Chem Inf Model2023
36948210Discovery of Nanomolar DCAF1 Small Molecule Ligands.J Med Chem2023
37214894SETDB1 Triple Tudor Domain Ligand, ( <i>R,R</i> )-59, Promotes Methylation of Akt1 in Cells.bioRxiv2023
36976643Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2.J Am Chem Soc2023
37360399Target 2035 - an update on private sector contributions.RSC Med Chem2023
36858798RAS and PP2A activities converge on epigenetic gene regulation.Life Sci Alliance2023
36651994Detection of antibodies against the huntingtin protein in human plasma.Cell Mol Life Sci2023
36802665Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21.J Med Chem2023
36732527Antecedent chromatin organization determines cGAS recruitment to ruptured micronuclei.Nat Commun2023
34782742A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization.Nat Chem Biol2022
35676539Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation.Nat Chem Biol2022
35578032PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.Nat Chem Biol2022
35363509Validating Small Molecule Chemical Probes for Biological Discovery.Annu Rev Biochem2022
35783295CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.Nat Rev Chem2022
35907431Enzymatic nucleosome acetylation selectively affects activity of histone methyltransferases in vitro.Biochim Biophys Acta Gene Regul Mech2022
36192397De novo design of immunoglobulin-like domains.Nat Commun2022
36288699Phosphorylation of the DNA repair scaffold SLX4 drives folding of the SAP domain and activation of the MUS81-EME1 endonuclease.Cell Rep2022
36191185Dissecting the stability determinants of a challenging de novo protein fold using massively parallel design and experimentation.Proc Natl Acad Sci U S A2022
36084291Combinatorial Anticancer Drug Screen Identifies Off-Target Effects of Epigenetic Chemical Probes.ACS Chem Biol2022
35244724The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase.Nucleic Acids Res2022
34936354Prediction and Validation of a Protein's Free Energy Surface Using Hydrogen Exchange and (Importantly) Its Denaturant Dependence.J Chem Theory Comput2022
34958585Correction to "Structure-Activity Relationship of USP5 Inhibitors".J Med Chem2022
33980013Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders.J Med Chem2021
33522809Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2.J Med Chem2021
33742187Protein arginine methylation: from enigmatic functions to therapeutic targeting.Nat Rev Drug Discov2021
33575256A Semi-automated Organoid Screening Method Demonstrates Epigenetic Control of Intestinal Epithelial Differentiation.Front Cell Dev Biol2021
33513288Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics*.ChemMedChem2021
33591753A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6.J Med Chem2021
33529165RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.J Clin Invest2021
33579912PRMT5 inhibition disrupts splicing and stemness in glioblastoma.Nat Commun2021
34880419Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1.Commun Biol2021
35211674Target 2035 - update on the quest for a probe for every protein.RSC Med Chem2021
34648286Structure-Activity Relationship of USP5 Inhibitors.J Med Chem2021
34662547Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells.J Mol Biol2021
34718722The human pseudouridine synthase PUS7 recognizes RNA with an extended multi-domain binding surface.Nucleic Acids Res2021
34188192MYC protein interactors in gene transcription and cancer.Nat Rev Cancer2021
34019286Identifying and Validating MYC:Protein Interactors in Pursuit of Novel Anti-MYC Therapies.Methods Mol Biol2021
34154424Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening.SLAS Discov2021
32367723Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.J Med Chem2020
33054974Correction: A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.Elife2020
33090784Epigenetics 2.0: Special Issue on Epigenetics-Call for Papers.J Med Chem2020
32609811Alternative splicing and allosteric regulation modulate the chromatin binding of UHRF1.Nucleic Acids Res2020
32917713LSD1 represses a neonatal/reparative gene program in adult intestinal epithelium.Sci Adv2020
32445698Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.Cell2020
32546577Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.Cancer Discov2020
  • 1 - 50 of 401

Recommended Authors

Gottfried Schatz Research Center, Medical University of Graz
Career Start Year 2005
Number of shared co-authors 18
National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 5
Celgene/Bristol-Myers Squibb Corporation
Career Start Year 2004
Number of shared co-authors 6
Stanford University
Career Start Year 2004
Number of shared co-authors 15
Institute of Enzymology, HUN-REN Research Centre for Natural Sciences
Career Start Year 2000
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 2000
Number of shared co-authors 0
The State University of New Jersey
Career Start Year 2000
Number of shared co-authors 4
Incyte Corporation
Career Start Year 2000
Number of shared co-authors 4
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2000
Number of shared co-authors 5
University of New Hampshire
Career Start Year 1999
Number of shared co-authors 4
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 12
The Manton Center for Orphan Disease Research, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 6
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1995
Number of shared co-authors 4
Max-Planck-Institute of Biochemistry
Career Start Year 1995
Number of shared co-authors 3
University of Texas Southwestern Medical Center
Career Start Year 1993
Number of shared co-authors 5
Institut de Genetique et de Biologie Moleculaire et Cellulaire
Career Start Year 1993
Number of shared co-authors 11
King's College London
Career Start Year 1993
Number of shared co-authors 17
Bridge Institute, University of Southern California
Career Start Year 1991
Number of shared co-authors 10
Technical University of Munich, Institute of Structural Biology
Career Start Year 1991
Number of shared co-authors 22
Inhibikase Therapeutics Inc.
Career Start Year 1991
Number of shared co-authors 3
Joint Center for Structural Genomics
Career Start Year 1988
Number of shared co-authors 6
University of Cambridge
Career Start Year 1987
Number of shared co-authors 22
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 10
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year 1984
Number of shared co-authors 6
Institute of Systems, The University of Liverpool
Career Start Year 1984
Number of shared co-authors 17
Medical Research Council - Laboratory of Molecular Biology
Career Start Year 1984
Number of shared co-authors 17
Yokohama City University
Career Start Year 1982
Number of shared co-authors 1
University of Duisburg-Essen
Career Start Year 1981
Number of shared co-authors 2
University of California berkeley
Career Start Year 1976
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 16

Collaborators

University of Toronto
Co-authored papers 72
University of Toronto, College St
Co-authored papers 68
University of Toronto
Co-authored papers 66
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 31
University of Toronto
Co-authored papers 28
Miami University
Co-authored papers 22
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 21
Central China Normal University
Co-authored papers 19
Princess Margaret Cancer Research Centre
Co-authored papers 18
Pacific Northwest National Laboratory
Co-authored papers 17
Center for Structural Biology of Infectious Diseases, University of Chicago
Co-authored papers 15
Rensselaer Polytechnic Institute
Co-authored papers 14
Dana-Farber Cancer Institute
Co-authored papers 13
Children's Hospital Research Foundation
Co-authored papers 13
University of Toronto
Co-authored papers 13
Instituto de Investigacion Sanitaria La Fe
Co-authored papers 12
the Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 11
Institute of Pharmaceutical Chemistry, Goethe University
Co-authored papers 10
University of Toronto
Co-authored papers 9
University of Toronto
Co-authored papers 9
The Hospital for Sick Children, University of Toronto
Co-authored papers 8
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 8
UNC Chapel Hill School of Medicine
Co-authored papers 8
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 8
College Street, University of Toronto
Co-authored papers 8
University of Toronto
Co-authored papers 8
The Hospital for Sick Children
Co-authored papers 8
School of Public Health, Capital Medical University
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7